Haven't read our recent publication on engineered #nanovesicles for #nucleicacids delivery yet?
In the following article we report the first findings and advantages of this novel small #RNA delivery system developed with INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA (ICMAB-CSIC) and Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca:
➡️ Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
✅ pH-sensitive nanovesicles with outstanding colloidal #stability.
✅ They protect nucleic acids such as #miRNA from possible #degradation and deliver them #intracellularly.
✅ PoC for the treatment of neuroblastoma disease, a pediatric cancer.
✅ Use of our green DELOS #technology for the #formulation of nanovesicles.
✅#Scalable and #GMP-compliant manufacturing process to ensure smooth access to clinical stages.
In conclusion, the pH-sensitive #nanocarriers reported here constitute a new platform for delivering small #RNA in vitro and in vivo and have the potential to be used for the treatment of high-risk #neuroblastoma, and also to treat or prevent other #cancers or human #diseases.
If you are interested in nucleic acid #delivery, do not hesitate to #contact us!
“Nanomol Technologies, S.L. ha participado en el Programa de Iniciación a la Exportación ICEX-Next, y ha contado con el apoyo de ICEX, así como con la cofinanciación de Fondos europeos FEDER, habiendo contribuido según la medida de los mismos, al crecimiento económico de esta empresa, su región y de España en su conjunto”